Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2025-10-07 00:00:00 ET · period of report 2025-10-03 · accession 0001437749-25-030648 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-10-07 | 2025-10-03 | AYTU | Disbrow Jarrett | Chief Business Off | A - Grant | $0.00 | +32.1K | 49.1K | +189% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-03 | A | A | 12,500 | $0.00 | 61,568 | D | — | — | (F2) Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027. |
| 2 | Common | Common Stock | 2025-10-03 | A | A | 19,606 | $0.00 | 49,068 | D | — | — | (F1) The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus. |